Registrar Corp Registrar Corp LinkedIn Registrar Corp Twitter Registrar Corp Facebook Registrar Corp Google+ Registrar Corp Youtube Channel Registrar Corp FDA News Blog
HomeDrugsU.S. FDA Active Pharmaceutical Ingredients (API)API Examples › U.S. FDA Regulations: Nifedipine

U.S. FDA Requirements: Nifedipine

Pharmaceutical / Drug Definition : Inhibits calcium transport into myocardial and vascular smooth muscle cells, suppressing contractions. Dilates main coronary arteries and arterioles and inhibits coronary artery spasm, increasing oxygen delivery to heart and decreasing frequency and severity of angina attacks.

Registrar Corp assists Nifedipine companies with:

  • FDA Registration Nifedipine
  • FDA Listing Nifedipine
  • FDA Label Requirements and Exceptions Nifedipine
  • FDA Import Information Nifedipine
  • FDA Detentions Nifedipine (Nifedipine Entry Refusal)
  • General U.S. Food and Drug Administration Guidelines for:
       - Manufacturers Nifedipine (Nifedipine Suppliers)
       - Processors Nifedipine
       - Repackers Nifedipine
       - Relabelers Nifedipine
       - Exporters Nifedipine
       - Importers Nifedipine
For more information about Nifedipine, simply click below:




Live Help

 
U.S. FDA Regulations:

U.S. FDA Regulation: 21 C.F.R. Part 207


Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
Home | About Us | News | Resources | Exhibitions | Seminars | Associations | Careers | Sitemap | Terms of Use © 2014 Registrar Corp
 
Food and Beverages | Drugs | Cosmetics | Medical Devices | Radiation-Emitting Electronic Devices | Color Additives | Tobacco